MannKind reported $26.97M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Adma Biologics USD 196.67M 5.21M Sep/2025
Dynavax Technologies USD 73.29M 2.4M Sep/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Halozyme Therapeutics USD 185.8M 4.29M Sep/2025
Insmed USD 120.96M 13.36M Sep/2025
MacroGenics USD 8.75M 530K Sep/2025
MannKind USD 26.97M 1.52M Sep/2025
Merck USD 6.44B 157M Sep/2025
Novo Nordisk DKK 42.85B 2B Mar/2025
Pfizer USD 11.47B 201M Sep/2025
Sanofi EUR 22.69B 1.81B Dec/2025